Perceptive Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,150,641
Closed -$14.4M 123
2022
Q3
$14.4M Hold
2,150,641
0.42% 55
2022
Q2
$9.05M Hold
2,150,641
0.28% 63
2022
Q1
$7.25M Hold
2,150,641
0.15% 92
2021
Q4
$6.77M Hold
2,150,641
0.1% 108
2021
Q3
$7.03M Hold
2,150,641
0.1% 111
2021
Q2
$9.07M Hold
2,150,641
0.12% 112
2021
Q1
$10.7M Hold
2,150,641
0.14% 96
2020
Q4
$27.2M Hold
2,150,641
0.29% 70
2020
Q3
$21.1M Hold
2,150,641
0.31% 68
2020
Q2
$21.4M Hold
2,150,641
0.35% 58
2020
Q1
$19.5M Hold
2,150,641
0.51% 42
2019
Q4
$19.8M Sell
2,150,641
-44,000
-2% -$312K 0.4% 47
2019
Q3
$12.9M Sell
2,194,641
-10,000
-0.5% -$106K 0.35% 51
2019
Q2
$26.5M Hold
2,204,641
0.61% 42
2019
Q1
$26.6M Buy
2,204,641
+330,862
+18% +$4.88M 0.75% 35
2018
Q4
$22.8M Buy
+1,873,779
New +$25.9M 0.87% 32
2015
Q4
Sell
-10,379
Closed -$195K 188
2015
Q3
$195K Buy
+10,379
New +$176K 0.02% 134

Other funds holding CNCE